Single-cell analyses revealed key tumor-infiltrating myeloid cell subsets associated with clinical outcomes in different subtypes of breast cancer
Dingjie Wu,
Si Chen,
Yijin Liu,
Bowen Yang,
Ruixin Li,
Feng Jin,
Fan Yao,
Yue Fang
Affiliations
Dingjie Wu
Department of Microbial and Biochemical Pharmacy, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, China
Si Chen
Department of Microbial and Biochemical Pharmacy, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, China
Yijin Liu
Department of Breast Surgery and Surgical Oncology, Research Unit of General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, China
Bowen Yang
Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, China
Ruixin Li
Department of Breast Surgery and Surgical Oncology, Research Unit of General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, China
Feng Jin
Department of Breast Surgery and Surgical Oncology, Research Unit of General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, China
Fan Yao
Department of Breast Surgery and Surgical Oncology, Research Unit of General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, China; Corresponding author.
Yue Fang
Department of Microbial and Biochemical Pharmacy, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, China; Corresponding author.
